Document:

EXHIBIT
10.3(b)

 

2004 EQUITY COMPENSATION PLAN

EMPLOYEE

RESTRICTED STOCK GRANT

 

TERM
SHEET

 

Cephalon, Inc. (“Company”)
as specified in the Compensation Award Notice of Restricted Stock Grant (“Notice”)
hereby grants to the person named in the Notice (“Grantee”) as of the date
printed on the Notice (“Date of Grant”), the right to receive from the Company
the total number of shares of restricted stock listed in the Notice, upon and
subject to the terms and conditions set forth below.

 

1.             Grant of Restricted Stock.

(a)           Subject
to the terms and conditions set forth herein and in the 2004 Equity
Compensation Plan (“Plan”), the Company hereby grants to Grantee, as of the
Date of Grant, the right to receive shares of the Company’s common stock (“Granted
Shares”) upon the lapse of certain restrictions in accordance with the terms of
the Plan and these terms and conditions.

 

(b)           This
grant shall become null and void unless the Grantee shall accept these terms
and conditions by executing the Employee Acknowledgement on the Compensation
Award sheet and returning it to Human Resources. The Company will not issue any
portion of the Granted Shares until all of the restrictions on that portion of
the Granted Shares have lapsed.

 

2.             Restrictions.

(a)           Restriction
Period.  The restrictions on the Granted
Shares (described in Section 2(b) below) shall lapse, and the Granted Shares
shall no longer be forfeitable (as described in Section 3 below), in accordance
with the following schedule:

 

	
  Date

  	
   

  	
  Granted
  Shares Becoming

  Nonforfeitable

  
	
  1st
  Anniversary

  	
   

  	
  25%
  of Granted Shares

  
	
  2nd
  Anniversary

  	
   

  	
  50%
  of Granted Shares

  
	
  3rd
  Anniversary

  	
   

  	
  75%
  of Granted Shares

  
	
  4th
  Anniversary

  	
   

  	
  100%
  of Granted Shares

  

 

(b)           The
period during which any portion of the Granted Shares actually remains subject
to the restrictions of Section 2(b) below is referred to herein 

 

1

 

and in the Plan as the “Restriction
Period” for such portion of the Granted Shares.

 

(c)           Restrictions
on Transfer; Shares Subject to Forfeiture. 
Grantee may not sell, assign, transfer, pledge or otherwise dispose of
any portion of the Granted Shares at any time during the Restriction Period for
such Granted Shares, except to a Successor Grantee (as defined in the Plan) or
as otherwise permitted under the Plan.

 

(d)           Certificates.  Unless the Granted Shares are forfeited
pursuant to Section 3 below, at the end of the Restriction Period applicable to
each portion of the Granted Shares, Grantee will be entitled to receive an
unrestricted certificate representing that portion of the Granted Shares.

 

3.             Termination of Employment, Death and Disability.

 

(a)           Should
Grantee’s employment by the Company or one of its subsidiaries terminate (other
than by reason of death) during the Restriction Period, Grantee will forfeit
all of the Granted Shares as to which the Restriction Period has not expired on
or before the effective date of such termination.

 

(b)           Should
Grantee die during the Restriction Period, all restrictions imposed under
Section 2(b) above with respect to such Granted Shares shall lapse and such
shares shall become transferrable and nonforfeitable.

 

4.             Privilege of Stock Ownership.

 

                Grantee shall not
have, with respect to any Granted Shares, the right to vote the shares or the
right to receive any cash or other dividends declared thereon, until the
Restriction Period has expired with respect to such Granted Shares.

 

5.             Certain
Corporation Transactions.

 

(a)           “Change
in Control” shall mean a change in ownership or control of the Company
effected through either of the following transactions: (i) the direct or
indirect acquisition by any person or related group of persons (other 

 

2

 

than the Company or a
person that directly or indirectly controls, is controlled by, or is under
common control with, the Company) of beneficial ownership (within the meaning
of Rule 13d-3 of the Exchange Act) of securities possessing more than thirty
percent (30%) of the combined voting power of the Company’s outstanding securities
pursuant to a tender or exchange offer made directly to the Company’s
stockholders which the Board does not recommend such stockholders to accept; or
(ii) a change in the composition of the Board over a period of twenty-four (24)
months or less such that a majority of the Board members ceases, by reason of
one or more contested elections for Board membership, to be comprised of
individuals who either: (1) have been Board members continuously since the
beginning of such period, or (2) have been elected or nominated for election as
Board members during such period by at least a majority of the Board members
described in clause (1) who were still in office at the time such election or
nomination was approved by the Board.

 

(b)           “Corporate
Transaction” shall mean either of the following stockholder-approved
transactions to which the Company is a party: (i) a merger or consolidation in
which securities possessing more than fifty percent (50%) of the combined
voting power of the Company’s outstanding securities are transferred to a
person or persons different from the persons holding those securities
immediately prior to such transaction, or (ii) the sale, transfer or other
disposition of more than 75% of the Company’s assets in a single or related
series of transactions.

 

(c)           “Involuntary
Termination” shall mean the termination of the service of any grantee under
the Plan which occurs by reason of (i) such individual’s involuntary dismissal
or discharge by the Company or the successor thereto for reasons other than
Misconduct (as defined below), or (ii) such individual’s voluntary resignation,
in either case following: (a) a change in his or her position with the Company
or the successor thereto which materially reduces his or her level of
responsibility, (b) a reduction in his or her level of compensation (including
base salary, significant fringe benefits or any nondiscretionary and
objective-standard incentive payment or bonus award) by more than ten percent
(10%) in the aggregate or (c) a relocation of such individual’s place of
employment by more than fifty (50) miles, only if such change, reduction or
relocation is effected by the Company or the successor thereto without the
individual’s consent.  For purposes of
this definition, the 

 

3

 

term “Misconduct”
means the commission of any act of fraud, embezzlement or dishonesty by a
grantee under the Plan, any unauthorized use or disclosure by such individual
of confidential information or trade secrets of the Company or its successor,
or any other intentional misconduct by such individual adversely affecting the
business or affairs of the Company or its successor in a material manner.  The foregoing definition shall not be deemed
to be inclusive of all the acts or omissions which the Company or its successor
may consider as grounds for the dismissal or discharge of Grantee.

 

(d)           In
the event of any Corporate Transaction, if the Restriction Period has not
expired with respect to any of the Granted Shares, the expiration of all such
Restriction Periods shall automatically accelerate so that immediately prior to
the specified effective date for such Corporate Transaction, all restrictions
applicable to the Granted Shares shall lapse. 
However, the restrictions on any Restricted Stock Grant shall not so
lapse if and to the extent: (i) such Grant is, in connection with such
Corporate Transaction, either to be assumed by the successor corporation or
parent thereof or to be replaced with a restricted stock grant for shares of
the capital stock of the successor corporation or parent thereof having
comparable value and terms, (ii) such Grant is to be replaced with a cash
incentive option or award of the successor corporation which preserves the
value of the Grant existing at the time of such Corporate Transaction and
provides for subsequent payout in accordance with the same vesting schedule
applicable to such Grant, (iii) such Grant is to be replaced by a grant under
another incentive program which the Committee determines is reasonably
equivalent in value, or (iv) the lapse of restrictions with respect to such
Restricted Stock Grant is subject to other limitations imposed by the Committee
at the time of the Grant.  The
determination of comparability under clauses (i), (ii) or (iii) above shall be
made by the Committee, and its determination shall be final, binding and
conclusive.

 

(e)           Upon
the cessation of service of a grantee under the Plan by reason of an
Involuntary Termination within thirty-six (36) months after a Corporate
Transaction in which his or her outstanding Grants are assumed or replaced
pursuant to clauses (d)(i), (ii) or (iii) above, all restrictions applicable to
each such Grant under clause (i) shall lapse with respect to the total number
of shares of stock at the time subject to such Grant, and the cash incentive
program under clause (ii) or other incentive program under clause (iii) shall 

 

4

 

become fully vested.  In addition, upon a Grantee’s cessation of
service by reason of an Involuntary Termination within thirty-six (36) months
after a Change in Control, all restrictions applicable to Restricted Stock
Grants shall lapse, with respect to the total number of shares of Company Stock
at the time subject to such Grant.

 

(f)            Immediately
following the consummation of a Corporate Transaction, this grant shall
terminate and cease to remain outstanding, except to the extent assumed by the
successor corporation or its parent company.

 

(g)           This
grant, if assumed in connection with a Corporate Transaction, shall be
appropriately adjusted, immediately after such Corporate Transaction, to apply
and pertain to the number and class of securities which would have been issued
to Grantee, upon consummation of such Corporate Transaction.

 

(h)           The
provisions of Section 5(d) shall not operate as a limitation on the Committee’s
discretionary authority, exercisable either at the time of the Grant or at any
time while the Grant remains outstanding, to provide for the lapse of all restrictions
applicable to a Restricted Stock Grant upon the occurrence of any change in the
Company’s organization, ownership or structure not otherwise within the
definition of a Corporate Transaction or a Change in Control.  The Committee also shall have full power and
authority to condition any such restriction lapse upon the Optionee’s cessation
of service by reason of an Involuntary Termination within a specified period
following any such event.

 

(i)            The
acceleration or substitution of Grants under this Section 5 shall in no way
affect the right of the Company to adjust, reclassify, reorganize or otherwise
change its capital or business structure or to merge, consolidate, dissolve,
liquidate or sell or transfer all or any part of its business or assets.

 

6.             Election to Withhold Shares.

 

Grantee may make
an election to satisfy the Company income tax withholding obligation with
respect to the Granted Shares by having shares withheld up to an amount that
does not exceed Grantee’s maximum marginal tax rate for federal (including
FICA), state and local tax liabilities. Such 

 

5

 

election must be
in the form and manner prescribed by the Committee.  If Grantee is a director or officer (within
the meaning of Rule 16a-1(f) promulgated under the Securities Exchange Act of
1934, as amended), such election must be irrevocable and must be made six
months prior to the date on which all restrictions lapse with respect to such
Granted Shares.

 

7.             Compliance with Laws and Regulations.

 

(a)           This
grant is subject to compliance by the Company and Grantee with all applicable
requirements of law relating thereto and with all applicable regulations of any
stock exchange on which shares of the Company’s common stock may be listed at
the time of such exercise and issuance.

 

(b)           In
connection with this grant, Grantee will execute and deliver to the Company
such representations in writing as may be requested by the Company so that it
may comply with the applicable requirements of federal and state securities
laws.

 

8.             Liability of Company.

 

(a)           If
the Granted Shares exceed, as of the Date of Grant, the number of shares that
may without shareholder approval be issued under the Plan, then this grant will
be void with respect to such excess shares unless shareholder approval of an
amendment sufficiently increasing the number of shares issuable under the Plan
is obtained in accordance with the provisions of the Plan.

 

(b)           The
inability of the Company to obtain approval from any regulatory body having
authority deemed by the Company to be necessary to the lawful issuance and sale
of any common stock pursuant to this option will relieve the Company of any
liability with respect to the non-issuance or sale of the common stock as to
which such approval is not obtained.

 

9.             No Employment Contract

 

Nothing herein or
in the Plan confers upon Grantee any right to continue in the employ of the
Company (or any subsidiary) or interferes with or restricts in any way the
rights of the Company (or any subsidiary), which are hereby 

 

6

 

expressly
reserved, to discharge Grantee at any time for any reason or no reason, with or
without cause.  Except to the extent the
terms of any employment contract between the Company (or any subsidiary) and
Grantee may expressly provide otherwise, neither the Company nor any of its
subsidiaries is under any obligation to continue the employment of Grantee for
any period of specified duration.

 

10.           Notices.

 

Any notice required to be
given or delivered to the Company under the terms herein will be in writing and
addressed to the Company in care of its Senior Vice President, Human Resources,
at its corporate office at 145 Brandywine Parkway, West Chester, Pennsylvania
19380.  Any notice required to be given
or delivered to Grantee will be in writing and addressed to Grantee at the
address provided on the notice of grant or such other address provided in
writing by Grantee to the Company.  All
notices will be deemed to have been given or delivered upon personal delivery
or upon deposit in the U.S. mail, postage prepaid and properly addressed to the
party to be notified.

 

11.           Construction.

 

(a)           These
terms and conditions and the grant evidenced hereby are made and granted
pursuant to the Plan and are in all respects limited by and subject to the
express terms and provisions of the Plan. Capitalized terms not otherwise
defined herein that are defined in the Plan shall have the meaning specified in
the Plan.

 

(b)           All
decisions of the Committee with respect to any question or issue arising under
the Plan or these terms and conditions will be conclusive and binding on all
persons having an interest in this grant.

 

7EXHIBIT
10.3(c)

 

2004
EQUITY COMPENSATION PLAN

NON-EMPLOYEE DIRECTOR

NON-QUALIFIED
STOCK OPTION

 

GRANT
AGREEMENT

 

THIS AGREEMENT is made as
of the               
day of               ,
200     (“Grant Date”) by and between Cephalon, Inc. (“Company”)
and                      
(“Grantee”).

 

RECITALS

 

A.            Grantee,
as a non-employee member of the Board of Directors of the Company (“Board”),
has been granted an option to purchase shares of the common stock of the
Company pursuant to Section 6(b) of the Cephalon, Inc. 2004 Equity Compensation
Plan (“Plan”).

 

B.            The
option granted to the Grantee is intended to be a non-qualified stock option (“NQSO”),
which does not satisfy Section 422 of the Internal Revenue Code of 1986, as
amended.

 

NOW, THEREFORE, it is hereby agreed as follows:

 

1.             Grant of Option.

 

Subject to the terms and
conditions set forth in this Agreement and the Plan, the Company hereby grants
to Grantee, as of the Grant Date, a NQSO to purchase the number of shares of
the common stock of the Company (“Option Shares”) specified on the attached
Notice of Grant of Stock Options (“Notice”), at the exercise price per share
set forth in the Notice.

 

This option shall become
null and void unless the Grantee accepts this Agreement by executing this
Agreement in the space provided on the last page of the Agreement and returning
it to the Company.

 

2.             Option Term.

 

Unless sooner terminated in accordance with the
provisions of the Plan or this Agreement, this option will terminate at the
close of business on the date specified on the Notice, but in no event shall
the option terminate later than ten years from the Grant Date, (“Expiration
Date”).

 

 

3.             Option Nontransferable.

 

(a)           Except as
described in subparagraph (b) below, this option is not transferable or assignable
by the Grantee other than by will or by the laws of descent and distribution,
and during the lifetime of the Grantee, this option is exercisable only by the
Grantee.

 

(b)           Anything
contained in subparagraph (a) above notwithstanding, the Grantee may transfer
this option to family members, or one or more trusts or other entities for the
benefit of or owned by family members, consistent with applicable securities
laws and in accordance with such procedures as the Company may prescribe;
provided that the Grantee receives no consideration for the transfer of the
option and the transferred option continues to be subject to the same terms and
conditions as were applicable to the option immediately before the transfer.

 

4.             Date of Exercise.

 

The option is fully
exercisable on the Grant Date.  The
option may be exercised in whole or in part, and will remain exercisable until
the sooner of the Expiration Date or termination of the option as described in
Paragraph 5 below.

 

5.             Termination of Director Status.

 

(a)           Should
the Grantee cease to be a member of the Board (other than by reason of death,
permanent disability, termination for cause or Involuntary Termination within
thirty-six (36) months of a Change of Control (as provided in Paragraph 8)),
this option will, solely to the extent that it is exercisable immediately prior
to such cessation of membership on the Board, remain exercisable during the
three-month period following the date of such cessation of such membership on
the Board; provided, however, in no event will this option be exercisable at
any time after the Expiration Date.

 

(b)           Should
the Grantee become permanently disabled and cease by reason thereof to be a
member of the Board, this option will, solely to the extent that it is
exercisable immediately prior to such cessation of membership on the Board,
remain exercisable during the one-year period following the date 

 

 

of such cessation of
membership on the Board; provided, however, in no event will this option be
exercisable at any time after the Expiration Date.  The Grantee will be deemed to be permanently
disabled if the Grantee is, by reason of any medically determinable physical or
mental impairment expected to result in death or to be of continuous duration
of not less than one year, unable to engage in any substantial gainful
employment.

 

(c)           Should
the Grantee die while a member of the Board (or during the three-month period
referred to in subparagraph (a) or during the one-year period referred to in
subparagraph (b)), this option, to the extent it is at the time outstanding
under the Plan, shall remain exercisable until the Expiration Date or earlier
surrender of this option.  The executors
or administrators of the Grantee’s estate or the Grantee’s heirs or legatees
(as the case may be) will have the right to exercise this option, during the
remainder of the option term.

 

(d)           Should
the Grantee’s membership on the Board be terminated for cause (including, but
not limited to, any act of dishonesty, unethical conduct, willful misconduct,
fraud or embezzlement, or any unauthorized disclosure of confidential
information or trade secrets), this option will immediately terminate and cease
to be exercisable when notice of such termination is given to the Grantee.

 

6.             Privilege of Stock Ownership.

 

The holder of this option
will have none of the rights of a stockholder with respect to the Option Shares
until such individual has exercised the option and has been issued a stock
certificate for the Option Shares.

 

7.             Manner of Exercising Option.

 

In order to exercise this
option with respect to all or any part of the Option Shares for which this
option is at the time exercisable, Grantee (or in the case of exercise after
Grantee’s death, Grantee’s executor, administrator, heir or legatee, as the
case may be) must take the following actions:

 

(a)           Execute
and deliver to the Senior Vice President of Human Resources of the Company a
stock purchase agreement in substantially the form of Exhibit A to this
Agreement (the “Purchase Agreement”), specifying the number of Option Shares
with respect to which the option is being exercised;

 

 

(b)           Pay
the aggregate exercise price for the purchased shares as specified by the Board
in one or more of the following alternative forms:  (i) full payment, in cash or by check payable
to the Company’s order, in the amount of the exercise price for the Option
Shares being purchased; (ii) full payment in shares of common stock of the
Company held for at least six months and having an aggregate fair market value
on the day of exercise (as determined under the terms of the Plan) equal to the
exercise price for the Option Shares being purchased; (iii) a combination of
shares of common stock of the Company held for at least six months and valued
at fair market value on the day of exercise (as determined under the terms of
the Plan) and cash or check payable to the Company’s order, equal in the
aggregate to the exercise price for the Option Shares being purchased; or (iv)
to the extent permitted by applicable law, by such other method as the Board
may approve; and

 

(c)           Furnish
the Company with appropriate documentation that the person or persons
exercising the option, if other than the Grantee, have the right to exercise
this option.

 

8.             Certain Company Transactions.

 

(a)           “Change
of Control” shall mean a change in ownership or control of the Company
effected through either of the following transactions: (i) the direct or
indirect acquisition by any person or related group of persons (other than the
Company or a person that directly or indirectly controls, is controlled by, or
is under common control with, the Company) of beneficial ownership (within the
meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as amended of
securities possessing more than thirty percent (30%) of the combined voting
power of the Company’s outstanding securities pursuant to a tender or exchange
offer made directly to the Company’s stockholders which the Board does not
recommend such stockholders to accept; or (ii) 
a change in the composition of the Board over a period of twenty-four
(24) months or less such that a majority of the Board members ceases, by reason
of one or more contested elections for Board membership, to be comprised of
individuals who either (1) have been Board members continuously since the beginning
of such period, or (2) have been elected or nominated for election as Board
members during such period by at least a majority of the Board members
described in clause (1) who were still in office at the time such election or
nomination was approved by the Board.

 

 

(b)           “Corporate
Transaction” shall mean either of the following stockholder-approved
transactions to which the Company is a party: (i) a merger or consolidation in
which securities possessing more than fifty percent (50%) of the combined
voting power of the Company’s outstanding securities are transferred to a
person or persons different from the persons holding those securities
immediately prior to such transaction, or (ii) the sale, transfer or other
disposition of more than 75% of the Company’s assets in a single or related
series of transactions.

 

c)             “Involuntary
Termination” shall mean the termination of the service of the Grantee which
occurs by reason of (i) such individual’s involuntary dismissal or discharge by
the Company or the successor thereto for reasons other than Misconduct (as
defined below), or (ii) such individual’s voluntary resignation, in either case
following: (a) a change in the Grantee’s position with the Company or the
successor thereto which materially reduces the Grantee’s level of
responsibility, (b) a reduction in the Grantee’s level of compensation
(including base salary, significant fringe benefits or any non-discretionary
and objective-standard incentive payment or bonus award) by more than ten
percent (10%) in the aggregate or (c) a relocation of the Grantee’s place of
employment by more than fifty (50) miles, only if such change, reduction or
relocation is effected by the Company or the successor thereto without the
Grantee’s consent.  For purposes of this definition,
the term “Misconduct” means the commission of any act of fraud,
embezzlement or dishonesty by the Grantee, any unauthorized use or disclosure
by such individual of confidential information or trade secrets of the Company
or its successor, or any other intentional misconduct by such individual
adversely affecting the business or affairs of the Company or its successor in
a material manner.  The foregoing
definition shall not be deemed to be inclusive of all the acts or omissions
which the Company or its successor may consider as grounds for the dismissal or
discharge of the Grantee.

 

(d)           Upon
the occurrence of a Corporate Transaction or upon Involuntary Termination of
the Grantee within thirty-six (36) months following a Change of Control, this
option shall remain exercisable until the Expiration Date or earlier surrender
of this option.

 

(e)           Immediately
following the consummation of a Corporate Transaction, this option shall
terminate and cease to remain outstanding, except to the extent assumed by the
successor corporation or its parent company.

 

 

9.             Compliance with Laws and Regulations.

 

 

(a)           The
exercise of this option and the issuance of Option Shares upon such exercise is
subject to compliance by the Company and Grantee with all applicable requirements
of law relating thereto and with all applicable regulations of any stock
exchange on which shares of the Company’s common stock may be listed at the
time of such exercise and issuance.

 

(b)           In
connection with the exercise of this option, Grantee will execute and deliver
to the Company such representations in writing as may be requested by the
Company so that it may comply with the applicable requirements of federal and
state securities laws.

 

10.           Liability of Company.

 

(a)           If
the Option Shares exceed, as of the Grant Date, the number of shares that may
without stockholder approval be issued under the Plan, then this option will be
void with respect to such excess shares unless stockholder approval of an
amendment sufficiently increasing the number of shares issuable under the Plan
is obtained in accordance with the provisions of the Plan.

 

(b)           The
inability of the Company to obtain approval from any regulatory body having
authority deemed by the Company to be necessary to the lawful issuance and sale
of any common stock pursuant to this option will relieve the Company of any
liability with respect to the non-issuance or sale of the common stock as to
which such approval is not obtained.

 

11.           No Employment Contract.

 

Nothing in this
Agreement, the Notice or in the Plan confers upon Grantee any right to continue
membership on the Board or interferes with or restricts in any way the rights
of the Company (or any subsidiary), which are hereby expressly reserved, to
discharge the Grantee at any time for any reason or no reason, with or without
cause.  Except to the extent the terms of
any written contract between the Company and the Grantee may expressly provide
otherwise, neither the Company nor any of its subsidiaries is under any
obligation to continue the Grantee’s membership on the Board for any period of
specified duration.

 

 

12.           Withholding.

 

Grantee hereby agrees to
make appropriate arrangements with the Company for the satisfaction of any
federal, state or local income tax withholding requirements applicable to the
exercise of this option.

 

13.           Notices.

 

Any notice required to be
given or delivered to the Company under the terms of this Agreement will be in
writing and addressed to the Company in care of its Senior Vice President,
Human Resources at its corporate office at 145 Brandywine Parkway, West
Chester, Pennsylvania, 19380.  Any notice
required to be given or delivered to the Grantee will be in writing and
addressed to the Grantee at the address indicated below the Grantee’s signature
line on the Agreement.  All notices will
be deemed to have been given or delivered upon personal delivery or upon
deposit in the U.S. mail, postage prepaid and properly addressed to the party
to be notified.

 

14.           Construction.

 

This Agreement, the
Notice and the option evidenced hereby are made and granted pursuant to the
Plan and are in all respects limited by and subject to the express terms and
provisions of the Plan.  Capitalized
terms not otherwise defined herein that are defined in the Plan shall have the meaning
specified in the Plan.

 

All decisions of the
Committee or the Board, as applicable, with respect to any question or issue
arising under the Plan or this Agreement will be conclusive and binding on all
persons having an interest in this option.

 

15.           Governing Law.

 

The interpretation,
performance and enforcement of this Agreement will be governed by the laws of
the Commonwealth of Pennsylvania.

 

 

[SIGNATURE PAGE FOLLOWS]

 

 

IN WITNESS WHEREOF, the
Company has caused this Agreement to be executed in duplicate on its behalf by
its duly authorized officer and the Grantee has also executed this Agreement in
duplicate, all as of the day and year indicated above.

 

	
   

  	
  For Cephalon, Inc.

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  

 

I hereby accept the
option described in this Agreement and the Notice, and I agree to be bound by
the terms of the Plan, this Agreement and the Notice.  I hereby further agree that all of the
decisions and determinations of the Committee and the Board, as applicable,
shall be final and binding.

 

	
   

  	
  Grantee:

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  Address: 

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]